选择慢性喘息型200例发作期入院病例分为硝苯啶治疗组125例,氨茶碱对照组75例,10天为一疗程。两组年龄、病程、症状体征,心电图、胸片具有可比性。结果显示,治疗组显效79例,有效36例,无效10例,有效率92%;对照组显效24例,有效30例,无效21例,有效率72%。两组对比差异显著(P< 0.05)。提导硝苯啶对慢喘支有一定治疗价值,近期疗效肯定。 Select 200 cases of chronic asthmatic attack admission cases were divided into nifedipine treatment group 125 cases, aminophylline control group 75 cases, 10 days for a course of treatment. Two groups of age, duration, symptoms and signs, ECG, chest X-ray comparable. The results showed that in the treatment group, 79 cases were markedly effective, 36 cases were effective, 10 cases were ineffective, and the effective rate was 92%. In the control group, 24 cases were markedly effective, 30 cases were effective, 21 cases were ineffective and the effective rate was 72%. The difference between the two groups was significant (P <0.05). Nifanidine to promote chronic bronchitis have a certain therapeutic value, the recent curative effect.